This review concluded that mitral valve repair was more beneficial than replacement surgery in patients with nonischaemic mitral valve disease. There were no differences in total mortality between repair and replacement of the ischaemic mitral valve in the long term. In view of the methodological weaknesses of the review, the authors' conclusions may not be reliable.
How were differences between studies investigated?
Statistical heterogeneity was assessed using a chi-squared test (Cochran's Q statistic) . Subgroup analyses were conducted by the aetiology of mitral valve disease.
Results of the review
Twenty-nine studies (n=10,154) were included. The authors did not report details of the study designs.
Total survival.
Patients undergoing mitral valve replacement had a 58% increased risk of dying compared with those undergoing mitral valve repair (21 studies; HR 1.58, 95% CI: 1.41, 1.78). There was no significant heterogeneity (p=0.23). The subgroup analysis showed a similar trend favouring repair for patients with degenerative/myxomatous aetiology (4 studies; HR 1.68, 95% CI: 1.39, 2.02), mixed aetiology (10 studies; HR 1.49, 95% CI: 1.24, 1.78) and rheumatic aetiology (2 studies; HR 2.33, 95% CI: 1.59, 3.43). However, differences between repair and replacement groups were not statistically significant for patients undergoing surgery on chordae tendineae (1 study) or those with ischaemic aetiology (4 studies).
Early mortality.
There was evidence showing a greater benefit for repair compared with replacement for early mortality (28 studies; OR 2.24, 95% CI: 1.78, 2.80). There was no evidence of statistical heterogeneity among studies (p=0.52). The subgroup analysis showed a similar trend favouring repair for patients with degenerative/myxomatous aetiology (4 studies; OR 1.93, 95% CI: 1.08, 3.44), ischaemic aetiology (6 studies; OR 2.01, 95% CI: 1.19, 3.40), mixed aetiology (14 studies; OR 2.39, 95% CI: 1.76, 3.26) and rheumatic aetiology (3 studies; OR 2.98, 95% CI: 1.45, 6.15). There were no difference between repair and replacement groups for patients undergoing surgery on chordae tendineae (1 study).
Reoperation and post-operative thromboembolism.
Reoperation rates were lower after replacement of the mitral valve than following repair, however, the difference was not statistically significant (6 studies; HR 0.88, 95% CI: 0.48, 1.62). Reasons for reoperation included technical mistakes and valve-related causes such as infection, progression of disease and thrombosis. The risk of developing post-operative thromboembolism was higher for replacement than for repair (5 studies; HR 1.86, 95% CI: 1.24, 2.81).
Authors' conclusions
Evidence provided support for repair compared with replacement surgery in patients with non-ischaemic mitral valve disease. There were no differences in total mortality between repair and replacement of the ischaemic mitral valve in the long term. Repair appeared to present a lower risk of developing thromboembolism. Treatment-related differences for the risk of reoperation are uncertain and require further trials.
CRD commentary
The inclusion criteria were clear in terms of the participants, intervention and outcomes, but were not explicit for the study design. Since only two databases were searched and only studies in English were included, it is highly likely that other relevant studies were omitted. Methods were used to reduce reviewer error and bias at the study selection stage, but the number of reviewers involved in the data extraction was not described. Some details of the individual studies were reported, but not the study designs. In addition, no quality assessment was performed, thus the results from these studies and any synthesis might not be reliable. There was no evidence of statistical heterogeneity but there is likely to have been clinical differences between the studies (e.g. in the surgical procedures). In view of these limitations and the absence of details of the study designs, it is not possible to determine whether a meta-analysis was appropriate, hence the conclusions may not be reliable.
